凉血解毒法治疗银屑病的临床及实验研究
|
摘要
银屑病是一种常见的慢性炎症性皮肤病,病程长,易反复发作,银屑病是遗传背景下,多种因素综合作用所致的身心疾病。其致病机制复杂,至今尚未阐明,临床常反复发作而且缺乏有效的根治药物和手段。目前治疗银屑病尚无突破性进展。
西医治疗近期疗效较好,但毒副作用大不能长期使用,停药后易复发加重,远期疗效差。中医药治疗银屑病采用中医整体观念、辨证论治和内治外治结合,坚持治疗疗效肯定而且副作用小,复发率低。因此采用中药内服加外用配合治疗银屑病是当前较好的一种治疗方法。
全文包括文献综述和研究报告两部分。
文献综述共两部分。第一部分综述了西医近年来对银屑病进行了大量的临床与实验研究,包括流行病学、病因及发病机制、治疗等不同方面的进展;第二部分综述了中医药治疗银屑病的临床与研究进展,包括银屑病的历史沿革,近代医家对银屑病病因病机的认识,以及中医内外治方法及近年的研究进展。
研究报告包括银屑病的方证研究、临床研究和实验研究三部分。
方证研究通过收集近二十年来治疗银屑病的110首方剂并整理统计分析,可以看出,中医治疗银屑病的分型论治,大多数医家主要从血分论治,分为血热型、血虚型、血瘀型三型。前三型所占总的比率共计89.1%。该统计也与临床实际所见相符。说明血分有热是银屑病发病的基本病因病机。而凉血解毒法是治疗银屑病基本方法。这和当代各皮肤科专家对银屑病血热型的病因病机的认识以及辨证施治是基本一致的。由于目前中医治疗银屑病的辨证分型太细,则与从血分论治大同小异,而且过于繁杂,不利于银屑病中医药治疗水平的总结和提高。所以有必要对银屑病的辨证分型论治以及常用中药进行规范统一,以有利于中医药治疗银屑病的进一步推广。
临床研究通过凉血解毒汤治疗寻常型银屑病血热证来进行临床验证。对照组采用复方青黛胶囊口服配合加味黄芩油膏外用进行治疗;实验组内服凉血解毒汤配合加味黄芩油膏外用治疗。经两个月的治疗。临床疗效显示,治疗组30人中显效率76.7%(显效23人),有效率23.3%(有效7人),无效率0;对照组30人中显效率23.3%(显效7人),有效率66.7%(有效20人),无效10%(无效3人)。两组疗效有明显差异(p＜0.05)。
实验研究包括两个实验部分。将50只BLBC小鼠分成五组,分别为空白组A,造模组B,对照组C(复方青黛胶囊配合加味黄芩油膏外用),实验一组D(凉血解毒汤配合加味黄芩油膏外用),和实验二组E(凉血解毒汤配合制克银灵软膏外用)。
第一部分是采用金黄色葡萄球菌肠毒素(SEB)作为超抗原对小鼠进行腹腔注射。诱导小鼠血清肿瘤坏死因子(TNF)升高作为模型,来用中药内服加外用进行治疗。结果显示相对于空白组A,造模组B而言无论是治疗组还是对照组都能明显降低小鼠血清TNF水平,提示中药治疗有效。
第二部分观察了各实验组对Jarrett和Spearman所提出的小鼠尾鳞片表皮模型的作用,结果显示相对于空白组A,造模组B而言对照组C、实验一组D和实验二组E均具有明显促进鼠尾鳞片表皮颗粒层形成的作用,能够使角化不全转变为正常角化。而对照组C和实验一组D相比无明显差异(P＞0.05),其中实验二组E有颗粒层的鳞片数增加更为明显,和对照组C实验一组D相比也有显著增加(P＜0.01)。
通过临床与实验研究显示中药凉血解毒汤加减配合克银灵软膏外用对银屑病血热型疗效较好。
Psoriasis is a common chronic ,recurrent, inflammatory disease of the skin. Psoriasis is a complex disease resulted from various etiological factors under the genetic background. It has comlex pathogenic mechanisms that cannot be explained by now. It tends to be recurrent attacks, but the effective radicular curative drugs and means are scarace . And there is no breakthrough in the therapy to Ps with both the TCM and the western medicine .
Obviously the curative effect of the western medicine in the near future is effective ,but with the long-term toxicity and side-effect. Treatment for Ps with traditional Chinese medicines has many advantages: positive effect but little side effect. So treatment to Ps with the TCM and external use is a better means by now.
This paper includes literature reviews and research reports.
Two literature reviews are included. The first reviews modern clinic and research development on the Ps. It gains special concerns of the academic circles' owing to its unknown etiological factors and pathogenesis. Besides, it is scarce of effective therapeutic tools. Considerable research has been performed on epidemiology, etiological factors, pathogenesis and therapy in recernt years. The second reviews Traditional Chinese clinic research and development on the Ps including its successive changes, the opinions of neoteric doctors on irs pathogenesis, medicial and surgical treatment.
This research reports are consisted of three parts.
First is the standardization of psoriasis about dieffrentiation - based treatment and the herbs. 110 prescriptions are collected to statistically analyzed. Most TCM doctors are likely to divide the Syndrome of Ps. to three kinds:blood heat, blood dryness and blood stasis .Accoridingly differently herbs are used to treat the three kinds Ps. above. Standardization of treatment to psoriasis with Chinese medicine is useful to improve levels of using Chinese medicine to treat Ps.
The second is about the clinic research. We have performed clinicial verification on blood-heat syndrome applying with the Liangxuejiedutang(LXJDT) and external drug-the Jiaweihuangqinyougao(JWHQYG) to approach its effect. There are 60 cases with blood -heat syndrome who are all use the external drug-the JWHQYG included in the clinical verification, and 30 applied with the LXJDT and the other 30 cases applied with the Fufangqingdaijiaonang(FFQDJN) for control. After two months treatment, the PASI scores on lesions of the two groups are different significantly from those two months ago.The clinical effective rate is up to 76.7%, total effect rate is 100%in LXJDT group;While in control group is 23.3% and 90% respectively.There is remarkable difference between the two groups.
The last one is about experimental research.The experiment consists of two texts.
In text one ,we use the SEB as the superantigen to produce the TNF in the mouses' blood. And then observed that different treatment to make TNF to reduced down to different levels. We concluded that all the treatment with Chinese herbs are remarkable reduced TNF levels.
In the model text of Jarrett, all the groups with Chinese herbs including the group of FFQDJN with JWHQYG(groupC),the group of LXJDT with JWHQYG(groupD) ,the group of LXJDT with Keyinlingruangao(KYLRG)(group E) can significantly prompt the formation of the scale epidermis cells of the tail(P<0.05). But group E compared with group D and C is higher(P<0.01).
All the researches indicated that applying LXJDT with KYLRG is the better way in treating blood-heat syndrome of Ps.
西医治疗近期疗效较好,但毒副作用大不能长期使用,停药后易复发加重,远期疗效差。中医药治疗银屑病采用中医整体观念、辨证论治和内治外治结合,坚持治疗疗效肯定而且副作用小,复发率低。因此采用中药内服加外用配合治疗银屑病是当前较好的一种治疗方法。
全文包括文献综述和研究报告两部分。
文献综述共两部分。第一部分综述了西医近年来对银屑病进行了大量的临床与实验研究,包括流行病学、病因及发病机制、治疗等不同方面的进展;第二部分综述了中医药治疗银屑病的临床与研究进展,包括银屑病的历史沿革,近代医家对银屑病病因病机的认识,以及中医内外治方法及近年的研究进展。
研究报告包括银屑病的方证研究、临床研究和实验研究三部分。
方证研究通过收集近二十年来治疗银屑病的110首方剂并整理统计分析,可以看出,中医治疗银屑病的分型论治,大多数医家主要从血分论治,分为血热型、血虚型、血瘀型三型。前三型所占总的比率共计89.1%。该统计也与临床实际所见相符。说明血分有热是银屑病发病的基本病因病机。而凉血解毒法是治疗银屑病基本方法。这和当代各皮肤科专家对银屑病血热型的病因病机的认识以及辨证施治是基本一致的。由于目前中医治疗银屑病的辨证分型太细,则与从血分论治大同小异,而且过于繁杂,不利于银屑病中医药治疗水平的总结和提高。所以有必要对银屑病的辨证分型论治以及常用中药进行规范统一,以有利于中医药治疗银屑病的进一步推广。
临床研究通过凉血解毒汤治疗寻常型银屑病血热证来进行临床验证。对照组采用复方青黛胶囊口服配合加味黄芩油膏外用进行治疗;实验组内服凉血解毒汤配合加味黄芩油膏外用治疗。经两个月的治疗。临床疗效显示,治疗组30人中显效率76.7%(显效23人),有效率23.3%(有效7人),无效率0;对照组30人中显效率23.3%(显效7人),有效率66.7%(有效20人),无效10%(无效3人)。两组疗效有明显差异(p＜0.05)。
实验研究包括两个实验部分。将50只BLBC小鼠分成五组,分别为空白组A,造模组B,对照组C(复方青黛胶囊配合加味黄芩油膏外用),实验一组D(凉血解毒汤配合加味黄芩油膏外用),和实验二组E(凉血解毒汤配合制克银灵软膏外用)。
第一部分是采用金黄色葡萄球菌肠毒素(SEB)作为超抗原对小鼠进行腹腔注射。诱导小鼠血清肿瘤坏死因子(TNF)升高作为模型,来用中药内服加外用进行治疗。结果显示相对于空白组A,造模组B而言无论是治疗组还是对照组都能明显降低小鼠血清TNF水平,提示中药治疗有效。
第二部分观察了各实验组对Jarrett和Spearman所提出的小鼠尾鳞片表皮模型的作用,结果显示相对于空白组A,造模组B而言对照组C、实验一组D和实验二组E均具有明显促进鼠尾鳞片表皮颗粒层形成的作用,能够使角化不全转变为正常角化。而对照组C和实验一组D相比无明显差异(P＞0.05),其中实验二组E有颗粒层的鳞片数增加更为明显,和对照组C实验一组D相比也有显著增加(P＜0.01)。
通过临床与实验研究显示中药凉血解毒汤加减配合克银灵软膏外用对银屑病血热型疗效较好。
Psoriasis is a common chronic ,recurrent, inflammatory disease of the skin. Psoriasis is a complex disease resulted from various etiological factors under the genetic background. It has comlex pathogenic mechanisms that cannot be explained by now. It tends to be recurrent attacks, but the effective radicular curative drugs and means are scarace . And there is no breakthrough in the therapy to Ps with both the TCM and the western medicine .
Obviously the curative effect of the western medicine in the near future is effective ,but with the long-term toxicity and side-effect. Treatment for Ps with traditional Chinese medicines has many advantages: positive effect but little side effect. So treatment to Ps with the TCM and external use is a better means by now.
This paper includes literature reviews and research reports.
Two literature reviews are included. The first reviews modern clinic and research development on the Ps. It gains special concerns of the academic circles' owing to its unknown etiological factors and pathogenesis. Besides, it is scarce of effective therapeutic tools. Considerable research has been performed on epidemiology, etiological factors, pathogenesis and therapy in recernt years. The second reviews Traditional Chinese clinic research and development on the Ps including its successive changes, the opinions of neoteric doctors on irs pathogenesis, medicial and surgical treatment.
This research reports are consisted of three parts.
First is the standardization of psoriasis about dieffrentiation - based treatment and the herbs. 110 prescriptions are collected to statistically analyzed. Most TCM doctors are likely to divide the Syndrome of Ps. to three kinds:blood heat, blood dryness and blood stasis .Accoridingly differently herbs are used to treat the three kinds Ps. above. Standardization of treatment to psoriasis with Chinese medicine is useful to improve levels of using Chinese medicine to treat Ps.
The second is about the clinic research. We have performed clinicial verification on blood-heat syndrome applying with the Liangxuejiedutang(LXJDT) and external drug-the Jiaweihuangqinyougao(JWHQYG) to approach its effect. There are 60 cases with blood -heat syndrome who are all use the external drug-the JWHQYG included in the clinical verification, and 30 applied with the LXJDT and the other 30 cases applied with the Fufangqingdaijiaonang(FFQDJN) for control. After two months treatment, the PASI scores on lesions of the two groups are different significantly from those two months ago.The clinical effective rate is up to 76.7%, total effect rate is 100%in LXJDT group;While in control group is 23.3% and 90% respectively.There is remarkable difference between the two groups.
The last one is about experimental research.The experiment consists of two texts.
In text one ,we use the SEB as the superantigen to produce the TNF in the mouses' blood. And then observed that different treatment to make TNF to reduced down to different levels. We concluded that all the treatment with Chinese herbs are remarkable reduced TNF levels.
In the model text of Jarrett, all the groups with Chinese herbs including the group of FFQDJN with JWHQYG(groupC),the group of LXJDT with JWHQYG(groupD) ,the group of LXJDT with Keyinlingruangao(KYLRG)(group E) can significantly prompt the formation of the scale epidermis cells of the tail(P<0.05). But group E compared with group D and C is higher(P<0.01).
All the researches indicated that applying LXJDT with KYLRG is the better way in treating blood-heat syndrome of Ps.
引文
1.张学军,陈珊宇,王福喜,等.寻常型银屑病遗传流行病学分析[J].中华皮肤科杂志,2000,33(6):383-385.
2.施曼绮,孙艳,伦文辉.银屑病中西医治疗学[M].中国医药科技出版社,1997,7.
3.杨国亮.现代皮肤病学[M].上海医科大学出版社,1996,512
4.Jee SH,Tsai TF,Liaw SH,et al.HLA-DRBI~*0701 and HLA-DRBI~*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population.Br J Dermatol,1998,139(6):978-983.
5.Mielants H,Veys EM,De Vos M,et al.The evolution of spondyloarthropathies in relation to gut histololy.J Rheumatol,1995,22(12):2266-2272.
6.Hohler T,Schneider PM,Rittner C,et al.LMP polymorphisms do not influence disease expression in psoriatic arthritis.Clin Exp Rheumatol,1996,14(6):661-664.
7.Schatteman L et al.Adv Exp Med Biol,1995,37(8):539-541.
8.Kirtschig G,Chow ET,Venning VA,et al.Acquired subepidermal bullous diseases.associated with psoriasis:a clinical,immunopathological and immunogenetic study.Br J Dermatol,1996,135(5):738 -745.
9.Michel G,Auer H,Kemeny L,et al.Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus(FK506).Biochem Pharmacol,1996,51(10):1315-1320.
10.Romero MR,Carroll JM,Watt FM.Analysis of cultured keratinocytes from a transgenic mouse model of psoriasis:effects of suprabasal integrin expression on keratinocyte adhesion,proliferation and terminal differentiation.Exp Dermatol,1999,8(1):53-67.
11.HenselerT,Christophers E.Psoriasis of early and late onset:characterization of two types of psoriasis vulgaris.J Am Acad Dermatol 1985;13:450-456.
12.Farber EM,Nall ML,Watson W.Natural history of psoriasis in 61 twin pairs.ArchDermatol 1974;109:207-211.13 Rosenberg EW et al.J Dennatol,1994;21(6):375- 381.
14.Farber EM,Nall ML.The natural history ofpsoriasis in 5600 patients.Dermatological 974;148:1-18.
15.王晓彦,刘玲玲,朱学骏.β-溶血型链球菌与角质形成细胞增殖和凋亡研究[J].中国皮肤性病学杂志,2000,14(5):296-297.
16.Tokura,et al.Arch Dermatol Res,1999,291(7-8):382.
17.Vaidimarsson H,et al.Clin Exp Immunol,1997,107(Suppl1):21.
18.张理涛,李瑞玲.链球菌抗原刺激的银屑病外周血单个核细胞培养上清液对角质形成细胞的作用[J].中国中西医结合皮肤性病学杂志,2003,201.
19.封绍奎.皮肤性病学[M].北京:中国协和医科大学出版社,2000,333.
20.Weissenbom,et al.J Invest Dermatol,1999,113(1):122.
21.Favre M,et al.J Invest Dermatol,1998,110(4):311.
22.杜孝元,韩范锡,向培德,等.从银屑病鳞屑中检出乙型肝炎病毒(HBV)成分[J].中华皮肤科杂志,1988,21(2):91.
23.杜孝元,蔡瑞康,赖进祥,等.从银屑病皮损组织中检出乙型肝炎病毒成分[J].解放军医学杂志,1989,14(6):414-415.
24.杜孝元,蔡瑞康,杨守纯,等.HBV-DNA及其表达产物在银屑病病损处组织中的定位与定量研究[J].中华微生物学和免疫学杂志,1995,15(3):199-201.
25.Bonifati C,et al.Clin Exp Dermatol,1994,19:383.
26.王刚,刘玉峰,爱滋病与银屑病[J].国外医学皮肤性病学分册,1995,21(1):14-16.
27.Rasenberg EW et al.Arch Dermatol,1982;118(3):143-144.
28.Rosenberg EW et al.Arch Dennatol,1982;118(6):370-371.
29.Economidou J,Barkis J,Demetriou Z,et al.Effects of cy-closporin A on immune activation markers in patients with active psoriasis.Dermatology,1999,199(2):144.
30.Nickoloff BJ.The search for pathogenic T cells and the geneticbasis of psoriasis using a severe combined immunodeficient mouse model.Cutis,2000,65(2):110.
31.陈周,饶汉珍,郭实士.银屑病患者白介素-6 和肿瘤坏死因子-α的测定[J].中华皮肤科杂志,1996,29(2):82.
32.张开明,刘梅青,尹兴平,等.银屑病患者血清可溶性肿瘤坏死因子受体水平的检测[J].中华医学杂志,1998,78(7):524.
33.Prpic L,Strbo N,Sotosek V,et al.Assessment of perforin expression in peripheral blood lymphocytes in psoriatic patientsduring exacerbation of disease.Acta Derm Venereol Suppl(Stockh),2000,211(1):14.
34.李萍,马俊弛,张开明,等.肿瘤坏死因子及其受体对银屑病患者外周血PBMC产生IL-8的影响[J].中华皮肤科杂志,2000,33(4):272.
35.王桂芝,刘成玉,纪新强,等.藻酸双酯钠对银屑病病人白细胞流变性及细胞粘附分子表达的影响[J].青岛大学医学院学报,2000,36(1):37-39.
36.Ristow HJ.A major factor contributing to epidermal proliferstion in inflammatory skin diseases appears to be inter-leukin-1 or a related protein.Proc Natl Acad Sci USA.1987:84(7):1940-1944.
37.王刚,范雪莉,刘云峰.可溶性白介素-2受体与皮肤病[J].国外医学皮肤性病学分册,1993,19(6):338-340.
38.Bonifati C,Carducci M,cordiali FP,et al.Correlated increases of tumornecrosis factor-alpha,interleukin-6 and granulocyte monocyte-colony stimulating fator levels in suntion blister fluids and sera of psoriasis patients-relationships with disease severity.Clin Exp Dermatol,1994,19:383-387.
39.Paquet P,Pierard GE.Interleuldn-6 and the skin.Int Arch Allergy Immunol,1996,109:308.
40.Neuner P,Urbanski Agatha,Trautinger F,et al.Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis.J Invest Dermatol,1991,97:27-33.
41.Bonifati C,Trento E,Cordiali-Fei P,eal.skin and in the sera of patients wit plaque-type psoriases.Clin Immunol Immunopathol 1997;83:41-44.
42.秦建中,王光超.银屑病患者的细胞因子异常[J].国外医学皮肤性病学分册,1992,18(5):257-260.
43.商刚,陈艳,郑淑云,等.寻常型银屑病初发疹IL-8的研究[J].航空航天医药,1997,8(1):1-2.
44.Schorder JM,Harry G,Janice Y,et al.Neutrophil-Activating Proteins in Psoriasis.J Invest Dermatol,1992,98:241-24.
45.郑书云,张岩,商刚,等.银屑病患者白介素8的观察[J].哈尔滨医科大学学报,1997,31(4):309-310.
46.钱起丰.银屑病及其它炎性皮肤病患者血清白介素8水平的观察[J].中华皮肤科杂志,1996,29(4):114-115.
47.赵庆利,吴鹏举.干扰素与银屑病[J].国外医学皮肤性病学分册,1992,18(6):327-329.
48.秦建中,王光超.银屑病患者的细胞因子异常[J].国外医学皮肤性病学分 册,1992,18(5):257-260.
49.Nickoloff BJ,Karabin GD,Barker JNWN,et al.Cellular Localization of interleukin-8 and its inducer,tumor necrosis factor-alpha in psoriasis.Am J Pathol,1991,138:129-140.
50.FbarerEM,BrihgtR,PNallML,etal.Psoriasis:aquestionaiersuvreyrof2114Patients [J]AcrhDemratol.1968,18(3):248.
51.Farber EM,et al.Cutis.1993,51:322.
52.李融,蔡志强.银屑病患者个性、应激及心理健康状况调查研究[J].铁道医学,1999,27(3):158-160.
53.陈静,鲁建云.角质形成细胞凋亡与银屑病病情的关系[J].中南大学学报(医学版),2006,31(6):936-939.
54.顾有守.银屑病治疗的进展[J].临床皮肤科杂志,1998,27(2):136-137.
55.顾伟程.现代皮肤病性病治疗学[M].北京:中国协和医科大学出版社,1999:439.
1.北京中医医院.赵炳南临床经验集[M].第1版北京:人民卫生出版社,1975,14048-3424.
2.中国中医研究院广安门医院编.现代著名老中医名著重刊丛书.朱仁康临床经验集[M]第1版 北京:人民卫生出版社2005,7-117-06969-4.
3.瞿幸.消银解毒饮治疗银屑病血热证85例临床观察[J].中医杂志2001,
4.周鸣岐.辨证分型治疗银屑病802例[J].中医杂志,1989,30(5):42.
5.张志礼.皮肤病临床经验[M].中国医药科技出版社,2001,115.
6.北京中医医院.赵炳南临床经验集[M].人民卫生出版社,1975,211-219.
7.朱仁康,邹铭西,李博鉴.克银方治疗银屑病(牛皮癣)的I临床研究[J].中医杂志,1981,22(4):22.
8.金起凤.消银解毒汤治疗银屑病58例疗效观察[J].辽宁中医杂志,1983,7(6):29-30.
9.丁履伸,赵绚德.银屑病的中医治疗[J].山东中医学院学报,1980,4(4):47-49.
10.顾伯华.外科经验集[M].上海:上海人民出版社,1977,252.
11.马绍尧,李咏梅.辨证治疗寻常型银屑病312例[J].湖南中医药导报,1999,5(7):21.
12.张晓杰.寻常型银屑病辨证论治的研究[J].山东中医药大学学报,1997,21(2):110-112.
13.李寿甫,杨占魁.脏腑辨证分型治疗银屑病1000例[J].陕西中医,1998,19(2):60.
14.李咏梅.从肝论治银屑病495例疗效观察[J].浙江中西医结合杂志,2007,17(12):776.
15.于豪.健脾除湿解毒法对沿海地区银屑病的治疗应用[J].安徽中医临床杂志,2001,13(2):101.
16.唐长华.李富玉从毒论治寻常型银屑病经验[J].山东中医药大学学报,2007,31(4):313.
17.韩晓冰.疏肝理气疗法治疗银屑病80例[J].河南中医,2007,27(3):53.
18.孙忠义.加味黄连解毒汤[J].湖北中医杂志,1980;(3):35.
19.王雅娟,董西林.活血通络汤治疗寻常型银屑病80例[J].陕西中医,2002,23(9):796-797.
20.宋坪.复方莪倍软膏治疗斑块状银屑病的临床观察[J].中国中西医结合杂志2007,27(4):352.
21.吴胜利.解毒化淤汤治疗银屑病的临床和实验研究[J].中华皮肤科杂志,2004,37(3):133-134.
22 徐建平.祛风活血方为主治疗银屑病84例临床观察[J].浙江中医杂志,2007,42(7):411.
23.宾光明.迪银片并复丹参注射液治疗银屑病的疗效观察[J].药物与临床 国际医药卫生导报,2007,13(22):54.
24.贾丽梅.消银灵软膏治疗寻常型银屑病89例[J].中国中医药科技,2007,14(1):24.
25.魏跃钢.清开灵注射液治疗银屑病94例[J].临床皮肤科杂志,1998,27(1):27.
26.武三卯,骆志成,张选奋,等.清开灵注射液治疗寻常型银屑病临床观察[J].中国皮肤性病学杂志,1995,9(4):241.
27.张力群,袁万图,张剑堑,等.双黄连粉针剂对小鼠免疫功能及血管通透性影响一 一附治疗68例银屑病疗效观察[J].中国中医药科技,1995,2(3):33.
28.李晓民.黄芪颗粒治疗寻常型银屑病疗效观察[J].中国麻风皮肤病杂志,2007,23(1):90.
29.张壤之.雷公藤多甙片配合中药治疗寻常型银屑病67例[J].皮肤病与性病2007,29(1):32.
30.王鹏.鱼腥草治疗寻常性银屑病疗效对比及远期随访观察[J].中国皮肤性病学杂志,2007,21(7):445.
31.梁庆生.复方甘草酸苷治疗寻常型银屑病的临床观察[J].赣南医学院学报,2007,27(1):104.
32.王小波.羟基喜树碱治疗银屑病临床观察[J].皮肤病与性病,2001,23(1):30.
33.秦小卫,郑茂荣,牟贤龙,等.银杏叶对银屑病患者中性粒细胞趋化反应的影响[J].临床皮肤科杂志,1998,27(3):154-155.
34.陈盈雯.银屑病患者口服银杏叶提取物治疗中IL-6水平变化[J].中西医结合皮肤性病学杂志,1996,(11):31.
35.吴京海,杨思源,金岚,等.丹参素对银屑病患者外周血单个核细胞粘附分子表达的影响[J].上海医科大学学报,1998,25(1):47-49.
36.娄卫海,张志礼,邓丙戍,等.凉血活血汤治疗进行期银屑病的临床及实验研究[J].中华皮肤科杂志,1999,32(2):80-81.
37.李伟凡,王萍,娄卫海.凉血活血汤治疗寻常型银屑病临床观察及肿留坏死因子和白介素8水平检测[J].临床皮肤科杂志,2002,31(12):770-772.
38.杨志波,向亚萍,欧阳恒.银屑病患者口服竹黄颗粒剂前后血清白介素6和肿瘤坏死因子α水平的比较[J].中华皮肤科杂志,2000,33(6):423.
39.刘铭,瞿幸,钱家骏,等.消银解毒饮对金黄色葡萄球菌肠毒素B型诱导小鼠血清白细胞介素28水平的影响[J].中国中西医结合杂志,2001,21(10):757-759.
40.张云璧,瞿幸,牛福玲.常用治疗银屑病的中药对肿瘤坏死因子α刺激后角质形成细胞生长及分泌白介素8的影响[J].中国中西医结合皮肤性病学杂志,2006,5(1):18-20.
41.崔飞婵,刘秀坚,周世锋.化瘀消银方对寻常型银屑病患者血清IL-15、IL-18水平的影响[J].中国中医药科技,2006,13(2):111.
42.范斌,李斌,沈健雄,等.凉血和活血中药对银屑病患者不同时期细胞因子的影响[J].中国中西医结合皮肤性病学杂志,2006,5(2):70-71.
43.李习舜.枸杞子对银屑病等皮肤病患者免疫功能的影响[J].中药药理与临床1988,4(2):45.
44.王英杰.复方甘草酸甘对银屑病患者T细胞免疫功能的影响[J].中国麻风皮肤病杂志,2007,23(6):533.
45.林瑞奋.三藤汤治疗寻常型银屑病临床及免疫学研究[J].福建中医学院学报,2000,10(3):8.
46.宋宁静,杨风清,宋兆友.复方青黛丸治疗银屑病的微循环观察[J].中国皮肤性病学杂志,1991,5(4):213-214.
47.李炎夏,周起云,王景学,等.黄芪维胺酯连联合应用对银屑病甲襞微循环的影响[J].中国皮肤性病学杂志,1998,12(6):345-346.
48.王秀敏.银屑病患者活血化瘀治疗前后血液流变学和甲襞微循环的变化[J].滨州医学院学报,1999,22(6):535.
49.李冠勇.银屑病中医分型与血小板指数及微循环的关系[J].新中医,1997,29(2): 38.
50.沈万宗.改善微循环药物在治疗银屑病中的应用[J].中国药业,1998,7(5):25.
51.符晓.银屑病三种治疗方法的疗效及对血浆中cA M P和cG M P的含量影响[J].中国康复,2004,19(1):32.
52.王乖娟.银屑宁胶囊对心得安致豚鼠银屑病样皮损NO和M DA水平的影响[J].中国中西医结合皮肤性病学杂志,2005,4(3):166.
53.王懿娜.紫杉醇溶液外用治疗豚鼠耳部银屑病样病理改变的疗效观察[J].中华皮肤科杂志,2004,37(3):156.
54.刘海杰.仙方消银片对银屑病模型小鼠尾部鳞片颗粒层细胞形成的影响[J].岭南皮肤性病科杂志,2006,13(2):80.
55.张晓杰.应用动物模型观察中草药复方内服治疗银屑病的机理[J].中国麻风皮肤病杂志,2000,16(2):107.
56.苏艳.复方治银霜对鼠尾鳞片表皮的实验研究[J].重庆医学,1999,28(4):309.
57.邓俐,张堂德,杜江.商陆皂苷甲对银屑病患者外周血单个核细胞产生Q肿瘤坏死因子和可溶性白介素2受体的影响[J].临床皮肤科杂志,2004,33(7):407.
58.李斌.中医“血分论治”对寻常型银屑病患者外周血单个核细胞IFN- γ/IL- 4表达影响的实验研究[J].上海中医药杂志,2007,41(11):5.
59.骆丹,徐文严,李锡林,等.PUVA照射与青黛丸口服对银屑病患者血cAMP、cGMP、SOD 及LPO含量的影响[J].中华皮肤科杂志,1997,30(2):105-106.
60.赵喜荣,李冠勇,季军捷,等.复方丹参液对银屑病患者血液MDA、SOD及红细胞四项指数的影响[J].临床皮肤科杂志,1995,(4):258-259.
61.杨志波,刘炽,欧阳恒,等.竹黄颗粒剂Ⅱ号对应激小鼠皮肤肥大细胞影响的实验研究[J].湖南中医学院学报,2002,(2):12-14.
1.江年琼,梁吉春,赵艳红.土茯苓的药理作用及临床研究概括[J].湖南中医学院学报,2002,(2):12-14.
2.中国人民解放军236部队.防治老年慢性气管炎资料选编[J].中医研究院,1971.39.
3.北京医学院基础部微生物教研组.中药对免疫细胞及其功能的作用Ⅰ.免疫特异玫瑰花方法(RFI)的探讨及中药对抗原的结合细胞的作用[J].北京医学院学报,1978,(3):156.
4.欧阳雄.清热解毒药治疗肿瘤的药理作用与应用[J].中成药研究,1987,(12):36.
5.朱建伟,郑广娟.川芎、丹参及其配伍对大鼠脑缺血再灌注损伤的不同影响[J].时珍国药研究,1997,8(3):232.
6.张慧云,欧阳蓉.丹参对中枢神经系统的抑制作用[J].药学学报,1979,14(5):288.
7.范世藩,孙立群,王志华,等.复方丹参对冠心病快速疗效的实验分析[J].药学学报,1979,14(4):199.
8.刘春林,于家富,阎逸生,等.丹参注射液对脑电图的影响[J].中西医结合杂志,1990,15(2):112.
9.党月兰,李淑玉,张玉琳,等.丹参注射液的镇痛作用[J].兰州医学院学报,1990,16(1):1.
10.李铁民.中国免疫学杂志,1989,12(增2):56.
11.Matao K.CA,1956,50:5647C
12.Palamarchuk A S,Bondarenko V E,1976,85:37126b
13.Baer H et al.J Biol Chem.1946,162:65
14.曾国琦,王静.中药威灵仙抗疟作用的初步探讨[J].福建医药杂志,1988,10(5):35.
15.李冬华,孙燕,吴廼居,等.广豆根提取物对肿瘤乏氧细胞选择毒性的研究(简报)[J].中国医学科学院学报,1988,10(1):39.
16.江崎俊治.日本药理学杂志,1966,62(1):76.
17.江西赣州专区卫生学校科研组.白花蛇舌草抗炎机制的探讨[J].新医药资料(江西药科学校),1970,(4):8.
18.Kalashnikova N A,Gerashchenko A L,Zemtsova G N,etal.CA,197684:99346m
19.熊谷藤男,等.Minophagen Med Rev,1987,17(supp):10.
20.葛明珠,张志琳,潘兴斌.18p-甘草次酸钠抗缺氧机理的初步探讨[J].中国药理学通报,1991,7(4):297.
21.小乔恭一.日本药学会103年会讲要,1983.276.
22.张昌绍.药理学[M].第二版.北京:人民卫生出版社,1965.252.
23.戈特曼LS.治疗学的药理基础[M].第一版.上海:上海科学技术出版社,1995.1076.
24.梅全喜,毕焕新.现代中药药理作用[M].北京:中国中医药出版社,1998.10.
1.Rosenberg EW,Noah PW,Skinner RB.Psoriasis is a visible Manifestation of the skinsdefense against micro-organisms with ketoconazole.J Dermatol 1994;21:375.
2.David HF.What's chiken and what's egg in Psoriasis.Lancet 1996;347:386.
3.Lenug DY,Travers JB,Norris DA,et al.The role of superantigens in skin disease.J Inve st Dermatol,1995,105(1 suppl):37s-42s
4.张峻岭,陈学荣,殷金珠.银屑病患者淋巴细胞对葡萄球菌和链球菌超抗原刺激的增殖反应[J].中华皮肤科杂志,1999,32:72.
5.Bour H,Demidem A,Garrigue JL,et al.In vitro T cell response to staphylococcal enterotoxin B supcrantigen in chronic plaque type psoriasis.Acta Derm Venereol,1995,21:218-221
6.Diaz-Guerra MJM.Nelaso M,Martin-Sanz P,et la.Evidence for common mechanisms in the transcriptional contral of type Ⅱ nitric oxide synthetase in isolated heptocytes.Requirement of NF-kaPPa B activation after stimulation with bacterial cell wall production and phorbolesters.J Biol chem.,1996,271:30114 - 30120.
7.林俊萍,张士发,毕桂娇等.寻常性银屑病皮损TNF-a、核因子kB及诱生型NO 酶表达.中华皮肤科杂志,1999;32(2):105.
8.吴荣荣,周君富.银屑病患者血浆NO、SOD、LPO的含量测定.中华皮肤科杂志,1999;32(4):76.
9.蓝天鹤,徐仲昌,侯助存,等.小蘖碱对细菌的抗生作用及其机制的初步研究[J].生理学报,1957,21(3):213.
10.张维西.Chinese Med.J,1949,67(12):648.
11.刘国声.中药抗生力研究(第一报)[J].中华新医学报,1950,1(2):95.
12.Chang N C.Proc.Soc.Exp.Biol &Med,1948,69:141.
13.曹仁烈,孙在原,王仲德,等.中药水浸剂在试管内抗皮肤真菌的观察[J].中华皮肤科杂志,1957,(4):286.
14.刘国声.中药抗生力研究[J].中华新医学报,1950,1(4):285.
15.赵宗越,何晓青,谢玉昆.26种中药对脑膜炎球菌的制菌实验[J].微生物学报,1960,8(2):171.
16.山东医学院微生物教研室.110种中药抗菌谱实验的初步结果[J].山东医学院学报,1959,(8):42.
17.张覃沐,等.几种抗疟药(常山硷乙、氯胍和环氯胍)及黄芩素等的抗阿米巴作用.武汉医学院学报,1958,(1):11.
18.江田昭英,等.代谢,1973,10(5),增刊号:730.
19.Hsu H Y.CA,1956,50:1217c.
20.蔡仙德,舒荣华,谭剑萍,等.黄芩甙锌络合物抗过敏作用的研究[J].铁道医学,1987,15(4):193.
21.蒋韵,吴芬芬,尹琰,等.黄芩甙-锌络合物对致敏豚鼠离体肺释放SRS-A作用的观察[J].铁道医学,1987,15(5):290.
22.王越,黄尔秀,王瑜钦,等.70种药用植物抗菌效能的试验[J].植物学报,1954,3(2):121.
23.徐仲吕.89种中药对志贺氏菌痢之体外抗生实验研究[J].中华医学杂志,1947,33(3-4):71.
24.西安医学院一院检验科.黄连、黄柏及小檗碱对痢疾杆菌及金黄色葡萄球菌抗生 作用的观察.西安医学院学报,1958,(5):40.
25.李楚銮,林书,王煜华.四十四种中药草药及其复方对各种的抗菌作用观察[J].福建中医药,1960,5(7):38.
26.曹松年,赵芳洲.中药复方及单位药对真菌的抑菌作用[J].中华医学杂志,1962,48(12):781.
27.孙迅.黄连黄芩等煎液抗皮癣真菌作用的研究(黄连、黄芩、黄柏、艾叶、厚朴、苦参)[J].中华医学杂志,1955,41(6):536.
28.郑武飞.普通中国草药在试管内对致病性及非致病性真菌的抗真菌力.中华医学杂志,195238(4):315.
29.曹仁烈,孙在原,王仲德.中药水浸剂在试管内抗皮肤真菌的观察[J].中华皮肤科杂志,1957,(4):286.
30.李笔怡.以硫磺为主治愈小儿脾肾阳虚泄泻[J].四川中医,1983,(2):31.
31.刘承煌,刘建,范维琥,等,寻常性银屑病患者血脂、TXB2、6-酮PGF1 α和血小板聚集功能的检测[J].中国皮肤性病学杂志,1998,12(3):135-136.
32.Jarrett,A.Comparative and experimental keratinization.In:Jarrett A eds,the physiology and pathophysiology of the skin.London:Academic Prss 1973,123
33.Spearman,R.I.C.and Jarrett,A.Biological comparison of isomers and chemicalforms of vitamin A.Br J Dermatol,1974,90:553
34.吴胜利,许能,陈建明,等.解毒化癖汤治疗银屑病的临床和实验研究[J].中华皮肤科杂志,2004,37(3):133-134.
35.宋茹,袁继民,王媛媛.复方苦参注射液治疗银屑病的实验研究[J].中国现代应用药学杂志,2002,19(3):177.
36.林熙然,黄畋.喜树碱治疗银屑病的临床观察及实验研究[J].中华皮肤科杂志,1982,15(4):210.
2.施曼绮,孙艳,伦文辉.银屑病中西医治疗学[M].中国医药科技出版社,1997,7.
3.杨国亮.现代皮肤病学[M].上海医科大学出版社,1996,512
4.Jee SH,Tsai TF,Liaw SH,et al.HLA-DRBI~*0701 and HLA-DRBI~*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population.Br J Dermatol,1998,139(6):978-983.
5.Mielants H,Veys EM,De Vos M,et al.The evolution of spondyloarthropathies in relation to gut histololy.J Rheumatol,1995,22(12):2266-2272.
6.Hohler T,Schneider PM,Rittner C,et al.LMP polymorphisms do not influence disease expression in psoriatic arthritis.Clin Exp Rheumatol,1996,14(6):661-664.
7.Schatteman L et al.Adv Exp Med Biol,1995,37(8):539-541.
8.Kirtschig G,Chow ET,Venning VA,et al.Acquired subepidermal bullous diseases.associated with psoriasis:a clinical,immunopathological and immunogenetic study.Br J Dermatol,1996,135(5):738 -745.
9.Michel G,Auer H,Kemeny L,et al.Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus(FK506).Biochem Pharmacol,1996,51(10):1315-1320.
10.Romero MR,Carroll JM,Watt FM.Analysis of cultured keratinocytes from a transgenic mouse model of psoriasis:effects of suprabasal integrin expression on keratinocyte adhesion,proliferation and terminal differentiation.Exp Dermatol,1999,8(1):53-67.
11.HenselerT,Christophers E.Psoriasis of early and late onset:characterization of two types of psoriasis vulgaris.J Am Acad Dermatol 1985;13:450-456.
12.Farber EM,Nall ML,Watson W.Natural history of psoriasis in 61 twin pairs.ArchDermatol 1974;109:207-211.13 Rosenberg EW et al.J Dennatol,1994;21(6):375- 381.
14.Farber EM,Nall ML.The natural history ofpsoriasis in 5600 patients.Dermatological 974;148:1-18.
15.王晓彦,刘玲玲,朱学骏.β-溶血型链球菌与角质形成细胞增殖和凋亡研究[J].中国皮肤性病学杂志,2000,14(5):296-297.
16.Tokura,et al.Arch Dermatol Res,1999,291(7-8):382.
17.Vaidimarsson H,et al.Clin Exp Immunol,1997,107(Suppl1):21.
18.张理涛,李瑞玲.链球菌抗原刺激的银屑病外周血单个核细胞培养上清液对角质形成细胞的作用[J].中国中西医结合皮肤性病学杂志,2003,201.
19.封绍奎.皮肤性病学[M].北京:中国协和医科大学出版社,2000,333.
20.Weissenbom,et al.J Invest Dermatol,1999,113(1):122.
21.Favre M,et al.J Invest Dermatol,1998,110(4):311.
22.杜孝元,韩范锡,向培德,等.从银屑病鳞屑中检出乙型肝炎病毒(HBV)成分[J].中华皮肤科杂志,1988,21(2):91.
23.杜孝元,蔡瑞康,赖进祥,等.从银屑病皮损组织中检出乙型肝炎病毒成分[J].解放军医学杂志,1989,14(6):414-415.
24.杜孝元,蔡瑞康,杨守纯,等.HBV-DNA及其表达产物在银屑病病损处组织中的定位与定量研究[J].中华微生物学和免疫学杂志,1995,15(3):199-201.
25.Bonifati C,et al.Clin Exp Dermatol,1994,19:383.
26.王刚,刘玉峰,爱滋病与银屑病[J].国外医学皮肤性病学分册,1995,21(1):14-16.
27.Rasenberg EW et al.Arch Dermatol,1982;118(3):143-144.
28.Rosenberg EW et al.Arch Dennatol,1982;118(6):370-371.
29.Economidou J,Barkis J,Demetriou Z,et al.Effects of cy-closporin A on immune activation markers in patients with active psoriasis.Dermatology,1999,199(2):144.
30.Nickoloff BJ.The search for pathogenic T cells and the geneticbasis of psoriasis using a severe combined immunodeficient mouse model.Cutis,2000,65(2):110.
31.陈周,饶汉珍,郭实士.银屑病患者白介素-6 和肿瘤坏死因子-α的测定[J].中华皮肤科杂志,1996,29(2):82.
32.张开明,刘梅青,尹兴平,等.银屑病患者血清可溶性肿瘤坏死因子受体水平的检测[J].中华医学杂志,1998,78(7):524.
33.Prpic L,Strbo N,Sotosek V,et al.Assessment of perforin expression in peripheral blood lymphocytes in psoriatic patientsduring exacerbation of disease.Acta Derm Venereol Suppl(Stockh),2000,211(1):14.
34.李萍,马俊弛,张开明,等.肿瘤坏死因子及其受体对银屑病患者外周血PBMC产生IL-8的影响[J].中华皮肤科杂志,2000,33(4):272.
35.王桂芝,刘成玉,纪新强,等.藻酸双酯钠对银屑病病人白细胞流变性及细胞粘附分子表达的影响[J].青岛大学医学院学报,2000,36(1):37-39.
36.Ristow HJ.A major factor contributing to epidermal proliferstion in inflammatory skin diseases appears to be inter-leukin-1 or a related protein.Proc Natl Acad Sci USA.1987:84(7):1940-1944.
37.王刚,范雪莉,刘云峰.可溶性白介素-2受体与皮肤病[J].国外医学皮肤性病学分册,1993,19(6):338-340.
38.Bonifati C,Carducci M,cordiali FP,et al.Correlated increases of tumornecrosis factor-alpha,interleukin-6 and granulocyte monocyte-colony stimulating fator levels in suntion blister fluids and sera of psoriasis patients-relationships with disease severity.Clin Exp Dermatol,1994,19:383-387.
39.Paquet P,Pierard GE.Interleuldn-6 and the skin.Int Arch Allergy Immunol,1996,109:308.
40.Neuner P,Urbanski Agatha,Trautinger F,et al.Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis.J Invest Dermatol,1991,97:27-33.
41.Bonifati C,Trento E,Cordiali-Fei P,eal.skin and in the sera of patients wit plaque-type psoriases.Clin Immunol Immunopathol 1997;83:41-44.
42.秦建中,王光超.银屑病患者的细胞因子异常[J].国外医学皮肤性病学分册,1992,18(5):257-260.
43.商刚,陈艳,郑淑云,等.寻常型银屑病初发疹IL-8的研究[J].航空航天医药,1997,8(1):1-2.
44.Schorder JM,Harry G,Janice Y,et al.Neutrophil-Activating Proteins in Psoriasis.J Invest Dermatol,1992,98:241-24.
45.郑书云,张岩,商刚,等.银屑病患者白介素8的观察[J].哈尔滨医科大学学报,1997,31(4):309-310.
46.钱起丰.银屑病及其它炎性皮肤病患者血清白介素8水平的观察[J].中华皮肤科杂志,1996,29(4):114-115.
47.赵庆利,吴鹏举.干扰素与银屑病[J].国外医学皮肤性病学分册,1992,18(6):327-329.
48.秦建中,王光超.银屑病患者的细胞因子异常[J].国外医学皮肤性病学分 册,1992,18(5):257-260.
49.Nickoloff BJ,Karabin GD,Barker JNWN,et al.Cellular Localization of interleukin-8 and its inducer,tumor necrosis factor-alpha in psoriasis.Am J Pathol,1991,138:129-140.
50.FbarerEM,BrihgtR,PNallML,etal.Psoriasis:aquestionaiersuvreyrof2114Patients [J]AcrhDemratol.1968,18(3):248.
51.Farber EM,et al.Cutis.1993,51:322.
52.李融,蔡志强.银屑病患者个性、应激及心理健康状况调查研究[J].铁道医学,1999,27(3):158-160.
53.陈静,鲁建云.角质形成细胞凋亡与银屑病病情的关系[J].中南大学学报(医学版),2006,31(6):936-939.
54.顾有守.银屑病治疗的进展[J].临床皮肤科杂志,1998,27(2):136-137.
55.顾伟程.现代皮肤病性病治疗学[M].北京:中国协和医科大学出版社,1999:439.
1.北京中医医院.赵炳南临床经验集[M].第1版北京:人民卫生出版社,1975,14048-3424.
2.中国中医研究院广安门医院编.现代著名老中医名著重刊丛书.朱仁康临床经验集[M]第1版 北京:人民卫生出版社2005,7-117-06969-4.
3.瞿幸.消银解毒饮治疗银屑病血热证85例临床观察[J].中医杂志2001,
4.周鸣岐.辨证分型治疗银屑病802例[J].中医杂志,1989,30(5):42.
5.张志礼.皮肤病临床经验[M].中国医药科技出版社,2001,115.
6.北京中医医院.赵炳南临床经验集[M].人民卫生出版社,1975,211-219.
7.朱仁康,邹铭西,李博鉴.克银方治疗银屑病(牛皮癣)的I临床研究[J].中医杂志,1981,22(4):22.
8.金起凤.消银解毒汤治疗银屑病58例疗效观察[J].辽宁中医杂志,1983,7(6):29-30.
9.丁履伸,赵绚德.银屑病的中医治疗[J].山东中医学院学报,1980,4(4):47-49.
10.顾伯华.外科经验集[M].上海:上海人民出版社,1977,252.
11.马绍尧,李咏梅.辨证治疗寻常型银屑病312例[J].湖南中医药导报,1999,5(7):21.
12.张晓杰.寻常型银屑病辨证论治的研究[J].山东中医药大学学报,1997,21(2):110-112.
13.李寿甫,杨占魁.脏腑辨证分型治疗银屑病1000例[J].陕西中医,1998,19(2):60.
14.李咏梅.从肝论治银屑病495例疗效观察[J].浙江中西医结合杂志,2007,17(12):776.
15.于豪.健脾除湿解毒法对沿海地区银屑病的治疗应用[J].安徽中医临床杂志,2001,13(2):101.
16.唐长华.李富玉从毒论治寻常型银屑病经验[J].山东中医药大学学报,2007,31(4):313.
17.韩晓冰.疏肝理气疗法治疗银屑病80例[J].河南中医,2007,27(3):53.
18.孙忠义.加味黄连解毒汤[J].湖北中医杂志,1980;(3):35.
19.王雅娟,董西林.活血通络汤治疗寻常型银屑病80例[J].陕西中医,2002,23(9):796-797.
20.宋坪.复方莪倍软膏治疗斑块状银屑病的临床观察[J].中国中西医结合杂志2007,27(4):352.
21.吴胜利.解毒化淤汤治疗银屑病的临床和实验研究[J].中华皮肤科杂志,2004,37(3):133-134.
22 徐建平.祛风活血方为主治疗银屑病84例临床观察[J].浙江中医杂志,2007,42(7):411.
23.宾光明.迪银片并复丹参注射液治疗银屑病的疗效观察[J].药物与临床 国际医药卫生导报,2007,13(22):54.
24.贾丽梅.消银灵软膏治疗寻常型银屑病89例[J].中国中医药科技,2007,14(1):24.
25.魏跃钢.清开灵注射液治疗银屑病94例[J].临床皮肤科杂志,1998,27(1):27.
26.武三卯,骆志成,张选奋,等.清开灵注射液治疗寻常型银屑病临床观察[J].中国皮肤性病学杂志,1995,9(4):241.
27.张力群,袁万图,张剑堑,等.双黄连粉针剂对小鼠免疫功能及血管通透性影响一 一附治疗68例银屑病疗效观察[J].中国中医药科技,1995,2(3):33.
28.李晓民.黄芪颗粒治疗寻常型银屑病疗效观察[J].中国麻风皮肤病杂志,2007,23(1):90.
29.张壤之.雷公藤多甙片配合中药治疗寻常型银屑病67例[J].皮肤病与性病2007,29(1):32.
30.王鹏.鱼腥草治疗寻常性银屑病疗效对比及远期随访观察[J].中国皮肤性病学杂志,2007,21(7):445.
31.梁庆生.复方甘草酸苷治疗寻常型银屑病的临床观察[J].赣南医学院学报,2007,27(1):104.
32.王小波.羟基喜树碱治疗银屑病临床观察[J].皮肤病与性病,2001,23(1):30.
33.秦小卫,郑茂荣,牟贤龙,等.银杏叶对银屑病患者中性粒细胞趋化反应的影响[J].临床皮肤科杂志,1998,27(3):154-155.
34.陈盈雯.银屑病患者口服银杏叶提取物治疗中IL-6水平变化[J].中西医结合皮肤性病学杂志,1996,(11):31.
35.吴京海,杨思源,金岚,等.丹参素对银屑病患者外周血单个核细胞粘附分子表达的影响[J].上海医科大学学报,1998,25(1):47-49.
36.娄卫海,张志礼,邓丙戍,等.凉血活血汤治疗进行期银屑病的临床及实验研究[J].中华皮肤科杂志,1999,32(2):80-81.
37.李伟凡,王萍,娄卫海.凉血活血汤治疗寻常型银屑病临床观察及肿留坏死因子和白介素8水平检测[J].临床皮肤科杂志,2002,31(12):770-772.
38.杨志波,向亚萍,欧阳恒.银屑病患者口服竹黄颗粒剂前后血清白介素6和肿瘤坏死因子α水平的比较[J].中华皮肤科杂志,2000,33(6):423.
39.刘铭,瞿幸,钱家骏,等.消银解毒饮对金黄色葡萄球菌肠毒素B型诱导小鼠血清白细胞介素28水平的影响[J].中国中西医结合杂志,2001,21(10):757-759.
40.张云璧,瞿幸,牛福玲.常用治疗银屑病的中药对肿瘤坏死因子α刺激后角质形成细胞生长及分泌白介素8的影响[J].中国中西医结合皮肤性病学杂志,2006,5(1):18-20.
41.崔飞婵,刘秀坚,周世锋.化瘀消银方对寻常型银屑病患者血清IL-15、IL-18水平的影响[J].中国中医药科技,2006,13(2):111.
42.范斌,李斌,沈健雄,等.凉血和活血中药对银屑病患者不同时期细胞因子的影响[J].中国中西医结合皮肤性病学杂志,2006,5(2):70-71.
43.李习舜.枸杞子对银屑病等皮肤病患者免疫功能的影响[J].中药药理与临床1988,4(2):45.
44.王英杰.复方甘草酸甘对银屑病患者T细胞免疫功能的影响[J].中国麻风皮肤病杂志,2007,23(6):533.
45.林瑞奋.三藤汤治疗寻常型银屑病临床及免疫学研究[J].福建中医学院学报,2000,10(3):8.
46.宋宁静,杨风清,宋兆友.复方青黛丸治疗银屑病的微循环观察[J].中国皮肤性病学杂志,1991,5(4):213-214.
47.李炎夏,周起云,王景学,等.黄芪维胺酯连联合应用对银屑病甲襞微循环的影响[J].中国皮肤性病学杂志,1998,12(6):345-346.
48.王秀敏.银屑病患者活血化瘀治疗前后血液流变学和甲襞微循环的变化[J].滨州医学院学报,1999,22(6):535.
49.李冠勇.银屑病中医分型与血小板指数及微循环的关系[J].新中医,1997,29(2): 38.
50.沈万宗.改善微循环药物在治疗银屑病中的应用[J].中国药业,1998,7(5):25.
51.符晓.银屑病三种治疗方法的疗效及对血浆中cA M P和cG M P的含量影响[J].中国康复,2004,19(1):32.
52.王乖娟.银屑宁胶囊对心得安致豚鼠银屑病样皮损NO和M DA水平的影响[J].中国中西医结合皮肤性病学杂志,2005,4(3):166.
53.王懿娜.紫杉醇溶液外用治疗豚鼠耳部银屑病样病理改变的疗效观察[J].中华皮肤科杂志,2004,37(3):156.
54.刘海杰.仙方消银片对银屑病模型小鼠尾部鳞片颗粒层细胞形成的影响[J].岭南皮肤性病科杂志,2006,13(2):80.
55.张晓杰.应用动物模型观察中草药复方内服治疗银屑病的机理[J].中国麻风皮肤病杂志,2000,16(2):107.
56.苏艳.复方治银霜对鼠尾鳞片表皮的实验研究[J].重庆医学,1999,28(4):309.
57.邓俐,张堂德,杜江.商陆皂苷甲对银屑病患者外周血单个核细胞产生Q肿瘤坏死因子和可溶性白介素2受体的影响[J].临床皮肤科杂志,2004,33(7):407.
58.李斌.中医“血分论治”对寻常型银屑病患者外周血单个核细胞IFN- γ/IL- 4表达影响的实验研究[J].上海中医药杂志,2007,41(11):5.
59.骆丹,徐文严,李锡林,等.PUVA照射与青黛丸口服对银屑病患者血cAMP、cGMP、SOD 及LPO含量的影响[J].中华皮肤科杂志,1997,30(2):105-106.
60.赵喜荣,李冠勇,季军捷,等.复方丹参液对银屑病患者血液MDA、SOD及红细胞四项指数的影响[J].临床皮肤科杂志,1995,(4):258-259.
61.杨志波,刘炽,欧阳恒,等.竹黄颗粒剂Ⅱ号对应激小鼠皮肤肥大细胞影响的实验研究[J].湖南中医学院学报,2002,(2):12-14.
1.江年琼,梁吉春,赵艳红.土茯苓的药理作用及临床研究概括[J].湖南中医学院学报,2002,(2):12-14.
2.中国人民解放军236部队.防治老年慢性气管炎资料选编[J].中医研究院,1971.39.
3.北京医学院基础部微生物教研组.中药对免疫细胞及其功能的作用Ⅰ.免疫特异玫瑰花方法(RFI)的探讨及中药对抗原的结合细胞的作用[J].北京医学院学报,1978,(3):156.
4.欧阳雄.清热解毒药治疗肿瘤的药理作用与应用[J].中成药研究,1987,(12):36.
5.朱建伟,郑广娟.川芎、丹参及其配伍对大鼠脑缺血再灌注损伤的不同影响[J].时珍国药研究,1997,8(3):232.
6.张慧云,欧阳蓉.丹参对中枢神经系统的抑制作用[J].药学学报,1979,14(5):288.
7.范世藩,孙立群,王志华,等.复方丹参对冠心病快速疗效的实验分析[J].药学学报,1979,14(4):199.
8.刘春林,于家富,阎逸生,等.丹参注射液对脑电图的影响[J].中西医结合杂志,1990,15(2):112.
9.党月兰,李淑玉,张玉琳,等.丹参注射液的镇痛作用[J].兰州医学院学报,1990,16(1):1.
10.李铁民.中国免疫学杂志,1989,12(增2):56.
11.Matao K.CA,1956,50:5647C
12.Palamarchuk A S,Bondarenko V E,1976,85:37126b
13.Baer H et al.J Biol Chem.1946,162:65
14.曾国琦,王静.中药威灵仙抗疟作用的初步探讨[J].福建医药杂志,1988,10(5):35.
15.李冬华,孙燕,吴廼居,等.广豆根提取物对肿瘤乏氧细胞选择毒性的研究(简报)[J].中国医学科学院学报,1988,10(1):39.
16.江崎俊治.日本药理学杂志,1966,62(1):76.
17.江西赣州专区卫生学校科研组.白花蛇舌草抗炎机制的探讨[J].新医药资料(江西药科学校),1970,(4):8.
18.Kalashnikova N A,Gerashchenko A L,Zemtsova G N,etal.CA,197684:99346m
19.熊谷藤男,等.Minophagen Med Rev,1987,17(supp):10.
20.葛明珠,张志琳,潘兴斌.18p-甘草次酸钠抗缺氧机理的初步探讨[J].中国药理学通报,1991,7(4):297.
21.小乔恭一.日本药学会103年会讲要,1983.276.
22.张昌绍.药理学[M].第二版.北京:人民卫生出版社,1965.252.
23.戈特曼LS.治疗学的药理基础[M].第一版.上海:上海科学技术出版社,1995.1076.
24.梅全喜,毕焕新.现代中药药理作用[M].北京:中国中医药出版社,1998.10.
1.Rosenberg EW,Noah PW,Skinner RB.Psoriasis is a visible Manifestation of the skinsdefense against micro-organisms with ketoconazole.J Dermatol 1994;21:375.
2.David HF.What's chiken and what's egg in Psoriasis.Lancet 1996;347:386.
3.Lenug DY,Travers JB,Norris DA,et al.The role of superantigens in skin disease.J Inve st Dermatol,1995,105(1 suppl):37s-42s
4.张峻岭,陈学荣,殷金珠.银屑病患者淋巴细胞对葡萄球菌和链球菌超抗原刺激的增殖反应[J].中华皮肤科杂志,1999,32:72.
5.Bour H,Demidem A,Garrigue JL,et al.In vitro T cell response to staphylococcal enterotoxin B supcrantigen in chronic plaque type psoriasis.Acta Derm Venereol,1995,21:218-221
6.Diaz-Guerra MJM.Nelaso M,Martin-Sanz P,et la.Evidence for common mechanisms in the transcriptional contral of type Ⅱ nitric oxide synthetase in isolated heptocytes.Requirement of NF-kaPPa B activation after stimulation with bacterial cell wall production and phorbolesters.J Biol chem.,1996,271:30114 - 30120.
7.林俊萍,张士发,毕桂娇等.寻常性银屑病皮损TNF-a、核因子kB及诱生型NO 酶表达.中华皮肤科杂志,1999;32(2):105.
8.吴荣荣,周君富.银屑病患者血浆NO、SOD、LPO的含量测定.中华皮肤科杂志,1999;32(4):76.
9.蓝天鹤,徐仲昌,侯助存,等.小蘖碱对细菌的抗生作用及其机制的初步研究[J].生理学报,1957,21(3):213.
10.张维西.Chinese Med.J,1949,67(12):648.
11.刘国声.中药抗生力研究(第一报)[J].中华新医学报,1950,1(2):95.
12.Chang N C.Proc.Soc.Exp.Biol &Med,1948,69:141.
13.曹仁烈,孙在原,王仲德,等.中药水浸剂在试管内抗皮肤真菌的观察[J].中华皮肤科杂志,1957,(4):286.
14.刘国声.中药抗生力研究[J].中华新医学报,1950,1(4):285.
15.赵宗越,何晓青,谢玉昆.26种中药对脑膜炎球菌的制菌实验[J].微生物学报,1960,8(2):171.
16.山东医学院微生物教研室.110种中药抗菌谱实验的初步结果[J].山东医学院学报,1959,(8):42.
17.张覃沐,等.几种抗疟药(常山硷乙、氯胍和环氯胍)及黄芩素等的抗阿米巴作用.武汉医学院学报,1958,(1):11.
18.江田昭英,等.代谢,1973,10(5),增刊号:730.
19.Hsu H Y.CA,1956,50:1217c.
20.蔡仙德,舒荣华,谭剑萍,等.黄芩甙锌络合物抗过敏作用的研究[J].铁道医学,1987,15(4):193.
21.蒋韵,吴芬芬,尹琰,等.黄芩甙-锌络合物对致敏豚鼠离体肺释放SRS-A作用的观察[J].铁道医学,1987,15(5):290.
22.王越,黄尔秀,王瑜钦,等.70种药用植物抗菌效能的试验[J].植物学报,1954,3(2):121.
23.徐仲吕.89种中药对志贺氏菌痢之体外抗生实验研究[J].中华医学杂志,1947,33(3-4):71.
24.西安医学院一院检验科.黄连、黄柏及小檗碱对痢疾杆菌及金黄色葡萄球菌抗生 作用的观察.西安医学院学报,1958,(5):40.
25.李楚銮,林书,王煜华.四十四种中药草药及其复方对各种的抗菌作用观察[J].福建中医药,1960,5(7):38.
26.曹松年,赵芳洲.中药复方及单位药对真菌的抑菌作用[J].中华医学杂志,1962,48(12):781.
27.孙迅.黄连黄芩等煎液抗皮癣真菌作用的研究(黄连、黄芩、黄柏、艾叶、厚朴、苦参)[J].中华医学杂志,1955,41(6):536.
28.郑武飞.普通中国草药在试管内对致病性及非致病性真菌的抗真菌力.中华医学杂志,195238(4):315.
29.曹仁烈,孙在原,王仲德.中药水浸剂在试管内抗皮肤真菌的观察[J].中华皮肤科杂志,1957,(4):286.
30.李笔怡.以硫磺为主治愈小儿脾肾阳虚泄泻[J].四川中医,1983,(2):31.
31.刘承煌,刘建,范维琥,等,寻常性银屑病患者血脂、TXB2、6-酮PGF1 α和血小板聚集功能的检测[J].中国皮肤性病学杂志,1998,12(3):135-136.
32.Jarrett,A.Comparative and experimental keratinization.In:Jarrett A eds,the physiology and pathophysiology of the skin.London:Academic Prss 1973,123
33.Spearman,R.I.C.and Jarrett,A.Biological comparison of isomers and chemicalforms of vitamin A.Br J Dermatol,1974,90:553
34.吴胜利,许能,陈建明,等.解毒化癖汤治疗银屑病的临床和实验研究[J].中华皮肤科杂志,2004,37(3):133-134.
35.宋茹,袁继民,王媛媛.复方苦参注射液治疗银屑病的实验研究[J].中国现代应用药学杂志,2002,19(3):177.
36.林熙然,黄畋.喜树碱治疗银屑病的临床观察及实验研究[J].中华皮肤科杂志,1982,15(4):210.